Deep intronic founder mutations identified in the ERCC4/XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum
Just a moment... >>> Read full article>>> Copyright for syndicated content belongs to the linked Source : National Academy of ...
Read more
